Molecular mechanisms of nutlin-induced apoptosis in multiple myeloma: evidence for p53-transcription-dependent and -independent pathways.
about
Novel strategies to target the ubiquitin proteasome system in multiple myelomaStructural insights into the transcription-independent apoptotic pathway of p53Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms.Molecular Mechanisms of p53 Deregulation in Cancer: An Overview in Multiple MyelomaTargeting p53 via JNK pathway: a novel role of RITA for apoptotic signaling in multiple myelomac-Abl mediates angiotensin II-induced apoptosis in podocytesp53 abnormalities and potential therapeutic targeting in multiple myeloma.Nutlin-3 treatment spares cisplatin-induced inhibition of bone healing while maintaining osteosarcoma toxicity.Targeting p53 by small molecules in hematological malignancies.Halofuginone inhibits multiple myeloma growth in vitro and in vivo and enhances cytotoxicity of conventional and novel agents.The ubiquitin-proteasomal system is critical for multiple myeloma: implications in drug discoveryTargeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.Pharmacologic activation of p53 by small-molecule MDM2 antagonistsTargeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy.Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agents.p53 haploinsufficiency and functional abnormalities in multiple myeloma.Nutlin's two roads toward apoptosis.Identification of the APC/C co-factor FZR1 as a novel therapeutic target for multiple myeloma.Targeting p53 by small molecule p53 activators in multiple myeloma.Downregulation of UBE2Q1 is associated with neuronal apoptosis in rat brain cortex following traumatic brain injury.Induction of apoptosis in Ehrlich ascites tumour cells via p53 activation by a novel small-molecule MDM2 inhibitor - LQFM030.Toxicogenomic responses of human liver HepG2 cells to silver nanoparticles.
P2860
Q26773246-E14656F4-9C3D-4C8C-A2AA-3BF68D016871Q27004001-4C8F22B2-A083-4FF4-9F31-64780B0C1040Q27692033-62E344EE-D941-4881-9A1E-7BBCCEF27BB4Q28074490-23474AD3-7B08-42ED-9AC1-EBB534EC6888Q28479002-62FF37E4-39B3-4519-B8DC-87B63D9CBD84Q28571893-F65F818C-4AB1-4A7A-AE94-72EAFA7CB23EQ33852683-46F05BCA-5D34-41CC-8CA1-BDAB1B2692D2Q33918015-864ADA09-2384-46F2-8343-7037630CB19EQ34636996-371BF7AF-097B-4DC6-BB10-F3D00FF81133Q35552714-B341E55C-24E1-4579-AF25-F874DC905398Q35824929-D82F1616-F26E-4A41-BEA7-3BD7B25DDAE9Q36172671-7BD338DE-07D6-4ED3-BAE7-1F51F180D13DQ36731603-F1D8C8E4-6D86-484F-818D-D9014049A751Q38059739-6879AE3B-13FD-43D0-92E3-A63563D0711CQ39009323-C17BDDD1-88FA-4DCF-AFCD-7563D508610AQ39015919-8870976D-87EE-4272-A8D9-8F972D0E60E7Q39666504-6A0DBA57-BA26-4738-93EF-F6662305ABB2Q41971182-7F09D7C9-12A0-4FD6-A31F-C29E5808DE25Q45764116-9A54B300-9AED-469B-BF1B-1BB01958AE90Q48908097-3D11E93A-1079-429C-A555-2331CFC97F1EQ50200634-8C493AA3-2B12-467C-AE88-264108E7952CQ52940731-083C37D2-0D88-42AA-916C-E243310FB4E6
P2860
Molecular mechanisms of nutlin-induced apoptosis in multiple myeloma: evidence for p53-transcription-dependent and -independent pathways.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Molecular mechanisms of nutlin ...... ent and -independent pathways.
@en
Molecular mechanisms of nutlin ...... ent and -independent pathways.
@nl
type
label
Molecular mechanisms of nutlin ...... ent and -independent pathways.
@en
Molecular mechanisms of nutlin ...... ent and -independent pathways.
@nl
prefLabel
Molecular mechanisms of nutlin ...... ent and -independent pathways.
@en
Molecular mechanisms of nutlin ...... ent and -independent pathways.
@nl
P2093
P2860
P356
P1476
Molecular mechanisms of nutlin ...... ent and -independent pathways.
@en
P2093
Hong Chang
Manujendra N Saha
P2860
P304
P356
10.4161/CBT.10.6.12535
P577
2010-09-01T00:00:00Z